Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsConstruction in ProgressCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Treasury Shares (2019 - 2026)

Dr Reddys Laboratories has reported Treasury Shares over the past 8 years, most recently at -$19.9 million for Q1 2026.

  • For Q1 2026, Treasury Shares rose 24.06% year-over-year to -$19.9 million; the TTM value through Mar 2026 reached -$19.9 million, up 24.06%, while the annual FY2026 figure was -$19.9 million, 173.54% down from the prior year.
  • Treasury Shares for Q1 2026 was -$19.9 million at Dr Reddys Laboratories, up from -$26.1 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $21.3 million in Q1 2022 and troughed at -$26.1 million in Q1 2025.
  • A 5-year average of $532573.0 and a median of $11.9 million in 2024 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: crashed 319.09% in 2025 and later grew 24.06% in 2026.
  • Year by year, Treasury Shares stood at $21.3 million in 2022, then fell by 27.5% to $15.4 million in 2023, then decreased by 22.7% to $11.9 million in 2024, then crashed by 319.09% to -$26.1 million in 2025, then rose by 24.06% to -$19.9 million in 2026.
  • Business Quant data shows Treasury Shares for RDY at -$19.9 million in Q1 2026, -$26.1 million in Q1 2025, and $11.9 million in Q1 2024.